234 related articles for article (PubMed ID: 36282488)
21. Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8
Grabowska J; Stolk DA; Nijen Twilhaar MK; Ambrosini M; Storm G; van der Vliet HJ; de Gruijl TD; van Kooyk Y; den Haan JMM
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33467048
[TBL] [Abstract][Full Text] [Related]
22. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives.
Gauthier J; Yakoub-Agha I
Curr Res Transl Med; 2017 Sep; 65(3):93-102. PubMed ID: 28988742
[TBL] [Abstract][Full Text] [Related]
23. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
Kosti P; Maher J; Arnold JN
Front Immunol; 2018; 9():1104. PubMed ID: 29872437
[TBL] [Abstract][Full Text] [Related]
24. Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.
Murad JM; Baumeister SH; Werner L; Daley H; Trébéden-Negre H; Reder J; Sentman CL; Gilham D; Lehmann F; Snykers S; Sentman ML; Wade T; Schmucker A; Fanger MW; Dranoff G; Ritz J; Nikiforow S
Cytotherapy; 2018 Jul; 20(7):952-963. PubMed ID: 30180944
[TBL] [Abstract][Full Text] [Related]
25. Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells.
Gao Z; Tong C; Wang Y; Chen D; Wu Z; Han W
J Genet Genomics; 2019 Aug; 46(8):367-377. PubMed ID: 31466926
[TBL] [Abstract][Full Text] [Related]
26. In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors.
Sun Z; Li R; Shen Y; Tan S; Ding N; Xu R; Wang X; Wei J; Liu B; Meng F
J Hematol Oncol; 2022 Mar; 15(1):29. PubMed ID: 35303900
[TBL] [Abstract][Full Text] [Related]
27. Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Driouk L; Gicobi JK; Kamihara Y; Rutherford K; Dranoff G; Ritz J; Baumeister SHC
Front Immunol; 2020; 11():580328. PubMed ID: 33384686
[TBL] [Abstract][Full Text] [Related]
28. Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy.
Ye B; Hu Y; Zhang M; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):185-191. PubMed ID: 36161298
[TBL] [Abstract][Full Text] [Related]
29. Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
Wang X; Walter M; Urak R; Weng L; Huynh C; Lim L; Wong CW; Chang WC; Thomas SH; Sanchez JF; Yang L; Brown CE; Pichiorri F; Htut M; Krishnan AY; Forman SJ
Clin Cancer Res; 2018 Jan; 24(1):106-119. PubMed ID: 29061640
[No Abstract] [Full Text] [Related]
30. Optimization of T Cell Redirecting Strategies: Obtaining Inspirations From Natural Process of T Cell Activation.
Gao Y; Wang Y; Luo F; Chu Y
Front Immunol; 2021; 12():664329. PubMed ID: 33981310
[TBL] [Abstract][Full Text] [Related]
31. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
[TBL] [Abstract][Full Text] [Related]
32. A Near-Infrared-II Fluorescent Nanocatalyst for Enhanced CAR T Cell Therapy against Solid Tumor by Immune Reprogramming.
Li H; Yang X; Wang Z; She W; Liu Y; Huang L; Jiang P
ACS Nano; 2023 Jun; 17(12):11749-11763. PubMed ID: 37319120
[TBL] [Abstract][Full Text] [Related]
33. Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces.
Dirar Q; Russell T; Liu L; Ahn S; Dotti G; Aravamudhan S; Conforti L; Yun Y
PLoS One; 2020; 15(9):e0238819. PubMed ID: 32976541
[TBL] [Abstract][Full Text] [Related]
34. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
35. Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation.
Xu F; Reiser M; Yu X; Gummuluru S; Wetzler L; Reinhard BM
ACS Nano; 2016 Jan; 10(1):1189-200. PubMed ID: 26720275
[TBL] [Abstract][Full Text] [Related]
36. Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice.
Li J; Zhou W; Li D; Huang Y; Yang X; Jiang L; Hu X; Yang J; Fu M; Zhang M; Wang F; Li J; Zhang Y; Yang Y; Yan F; Gao H; Wang W
Cancer Lett; 2023 Aug; 568():216287. PubMed ID: 37392990
[TBL] [Abstract][Full Text] [Related]
37. Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors.
Stock S; Benmebarek MR; Kluever AK; Darowski D; Jost C; Stubenrauch KG; Benz J; Freimoser-Grundschober A; Moessner E; Umana P; Subklewe M; Endres S; Klein C; Kobold S
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902133
[TBL] [Abstract][Full Text] [Related]
38. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
39. Stiffness of HIV-1 Mimicking Polymer Nanoparticles Modulates Ganglioside-Mediated Cellular Uptake and Trafficking.
Eshaghi B; Alsharif N; An X; Akiyama H; Brown KA; Gummuluru S; Reinhard BM
Adv Sci (Weinh); 2020 Sep; 7(18):2000649. PubMed ID: 32999830
[TBL] [Abstract][Full Text] [Related]
40. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169.
Puryear WB; Akiyama H; Geer SD; Ramirez NP; Yu X; Reinhard BM; Gummuluru S
PLoS Pathog; 2013; 9(4):e1003291. PubMed ID: 23593001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
